Trading Signals: AMGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Amgen)
| AMGN latest price $191.1600 (0.57%) ($190.4700 - $192.0608) on Fri. Mar. 1, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.68% (three month average) | RSI | 70 | Latest Price | $191.1600(0.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AMGN advances 0.4% a day on average for past five trading days. | Weekly Trend | AMGN advances 1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support AMGN advance at 0% a week (0% probability) IFRA(40%) XHB(29%) VIXM(20%) TLT(8%) VCIT(5%) | Factors Impacting AMGN price | AMGN will decline at least -0.84% in a week (0% probabilities). EMHY(-19%) SPLV(-18%) INDA(-18%) DIA(-17%) XLK(-16%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.84% (StdDev 1.68%) | Hourly BBV | 0 () | Intraday Trend | -0.1% | | | |
|
5 Day Moving Average | $190.51(0.34%) | 10 Day Moving Average | $188.87(1.21%) | 20 Day Moving Average | $187.47(1.97%) | To recent high | -5.5% | To recent low | 8% | Market Cap | $112.096b | | | | Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA. |